Ziftomenib；KO539
Product Detail
Product Tags
| Pack Size | Availability | Pretium (USD) |
| 0.1G | In Stock | 650 |
| 0.5G | In Stock | 970 |
| 1G | In Stock | 1350 |
Nomen chemicum:
(S) -4-Methyl-5-((4-((2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno(2,3-d)pyrimidin-4-yl)amino)piperidin -1-yl) methyl) -1-(2-(4-(methylsulfonyl)piperazin-1-yl)propyl)-1H-indolum-2-carbonitrile
SMILES Code:
N#CC(N1C[C@@H](N2CCN(S(=O)(C)=O)CC2)C)=CC3=C1C=CC(CN4CCC(NC5=C(C=C(CC)F) (F)F)S6)C6=NC(NC)=N5)CC4)=C3C*
InChi Code:
InChI=1S/C33H42F3N9O2S2/c1-21(43-11-13-44(14-12-43)49(4,46)47)19-45-25(18-37)15-27-22(2). 23(5-6-29(27)45)20-42-9-7-24(8-10-42)39-30-28-16-26(17-33(34,35)36)48- 31(28)41-32(38-3)40-30/h5-6,15-16,21,24H,7-14,17,19-20H2,1-4H3,(H2,38,39,40; ,41)/t21-/m0/s1
InChi Key:
BGGALFIXXQOTPY-NRFANRHFSA-N
Keyword:
2134675-36-6； CAS：2134675-36-6；CAS:2134675-36-6；Ziftomenib; KO539; KO 539; KO-539
Solubilitas:Ad determinandum
Repono:Arida, obscura et ad 0 - 4 C ad terminum brevem (dies ad septimanas) vel -20 C ad terminum longum (menses ad annos).
Descriptio:
Ziftomenib (KO-539) est inhibitor menin MLL commercii cum actione oralis.
Target: menin-MLL
